GFM1 and epilepsy: Epilepsy was also an important clinical manifestation of GFM1‐linked disease, about 41% of patients suffered from epilepsy (Barcia et al., 2020; Calvo et al., 2012; Ravn et al., 2015; Simon et al., 2017; Smits et al., 2011).